Abbott Stock Crash: Rebound Could Be Coming Fast [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories' stock price sell-off is overblown and unrealistic, providing an attractive opportunity in Q2. Institutions and analysts are accumulating this stock, indicating solid double-digit upside potential. Acquisitional woe hinders price action in April, but sets the market up for positive surprises and rebound later this year. Interested in Abbott Laboratories? Here are five stocks we like better. Abbott Laboratories' (NYSE: ABT) share price corrected by approximately 45% from peak to trough, bottoming in early Q2 2026 after reaching incredibly oversold levels ? Rocket Lab Is Back at a Line in the Sand—Now What? While there is cause for this sell-off, the depth of it is unreasonable, given the factors involved. The takeaway is that mixed results at the end of 2025 were compounded by tepid guidance and a questionable acquisition plan, leaving the overly eager market feeling cold. The question is which market participants are doing the selling, and which ones a
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [Yahoo! Finance]Yahoo! Finance
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test [TheStreet.com]TheStreet.com
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection TestPR Newswire
- Abbott Laboratories (ABT) had its price target lowered by Royal Bank Of Canada from $135.00 to $130.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website